21st Century Neurology

Phoenix, Arizona 85013

0 studies enrolling now · 17 studies all time

What they study most

Alzheimer's Disease, Chronic Migraine, Migraine, Migraine Disorders, Migraine Headache, Migraine With or Without Aura, Mild to Severe Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease Dementia, Relapsing Multiple Sclerosis, Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) — Running, not enrolling
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
• Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine — Completed
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study — Completed
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility — Completed
• A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease — Stopped early
• A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease — Completed
• The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease — Completed
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) — Completed
• EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease — Stopped early